Cholesterol-lowering drugs
Amgen vs Sanofi – A chronology of the patent battle over Repatha and Praluent
For more than ten years, Amgen, Sanofi and Regeneron were embroiled in a global patent battle to force each other's products off the market. Both side
...
13 March 2026 by Mathieu Klos